BYOT Byotrol Plc

TIDMBYOT

RNS Number : 8469U

Byotrol PLC

03 August 2020

B y otrol Plc

( " B y o t rol" or the "Group")

Update on current trading

Trading for the current financial year to 31 March 2021 remains strong across the whole Group and multiple opportunities continue to be available, across both product sales and IP licensing.

Product sales for the first quarter to 30 June exceeded GBP3.4m and orders for July and August continue to look encouraging. Our order book at the end of June stood at approximately GBP2m. Our current net cash position is healthy at GBP1.8m.

Whilst it is early in the year, assuming continued easing in supply chains and a relatively orderly Brexit, the Board would expect revenue and EBITDA for the current financial year to be significantly ahead of current market expectations.

We expect to announce the results for the year ended 31 March 2020 in mid September along with a further update on trading.

David Traynor, Chief Executive of Byotrol plc commented :

"Trading remains strong in all our markets and supply chains continue to ease to our benefit. We remain very confident in the outlook for the Group, both for the current year and in the longer term."

Enquiries:

Byotrol plc

David Traynor - Chief Executive Officer

Nic Hellyer - Chief Financial Officer 01925 742 000

finnCap

   Geoff Nash/Kate Bannatyne - Corporate Finance                             020 7220 0500 

Richard Chambers - ECM

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon +44 (0)207 129 1474

byotrol@flagstaffcomms.com

This announcement is released by Byotrol plc and, prior to publication, the information contained herein was deemed to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014. Such information is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to byotrol.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TSTQLLFBBVLLBBL

(END) Dow Jones Newswires

August 03, 2020 02:00 ET (06:00 GMT)

Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Lug 2023 a Lug 2024